Multiple Autonomous Vehicle Solutions to Minefield Reconnaissance and Mapping

Proceedings of Australian-American Joint Conference on the Technologies of Mines and Mine Countermeasures, Sydney, Australia, July 12-16, 199

Estimation of Directional Wave Spectra from an Autonomous Underwater Vehicle (AUV)

Proceedings of 11th International Symposium on Unmanned Untethered Submersible Technology (UUST'99), August 22-25, 199

Tactical Decision Aids Using Modeling and Simulation

N0001403WR2006

Spatial scaling properties of coral reef benthic communities

The spatial structure of ecological communities on tropical coral reefs across seascapes and geographies have historically been poorly understood. Here we addressed this for the first time using spatially expansive and thematically resolved benthic community data collected around five uninhabited central Pacific oceanic islands, spanning 6° latitude and 17° longitude. Using towed-diver digital image surveys over ~140 linear km of shallow (8–20 m depth) tropical reef, we highlight the autocorrelated nature of coral reef seascapes. Benthic functional groups and hard coral morphologies displayed significant spatial clustering (positive autocorrelation) up to kilometre-scales around all islands, in some instances dominating entire sections of coastline. The scale and strength of these autocorrelation patterns showed differences across geographies, but patterns were more similar between islands in closer proximity and of a similar size. For example, crustose coralline algae (CCA) were clustered up to scales of 0.3 km at neighbouring Howland and Baker Islands and macroalgae were spatially clustered at scales up to ~3 km at both neighbouring Kingman Reef and Palmyra Atoll. Of all the functional groups, macroalgae had the highest levels of spatial clustering across geographies at the finest resolution of our data (100 m). There were several cases where the upper scale at which benthic community members showed evidence of spatial clustering correlated highly with the upper scales at which concurrent gradients in physical environmental drivers were spatially clustered. These correlations were stronger for surface wave energy than subsurface temperature (regardless of benthic group) and turf algae and CCA had the closest alignments in scale with wave energy across functional groups and geographies. Our findings suggest such physical drivers not only limit or promote the abundance of various benthic competitors on coral reefs, but also play a key role in governing their spatial scaling properties across seascapes

Nonlocal appearance of a macroscopic angular momentum

We discuss a type of measurement in which a macroscopically large angular momentum (spin) is "created" nonlocally by the measurement of just a few atoms from a double Fock state. This procedure apparently leads to a blatant nonconservation of a macroscopic variable - the local angular momentum. We argue that while this gedankenexperiment provides a striking illustration of several counter-intuitive features of quantum mechanics, it does not imply a non-local violation of the conservation of angular momentum.Comment: 10 pages, 1 figur

Reduction and Emergence in Bose-Einstein Condensates

A closer look at some proposed Gedanken-experiments on BECs promises to shed light on several aspects of reduction and emergence in physics. These include the relations between classical descriptions and different quantum treatments of macroscopic systems, and the emergence of new properties and even new objects as a result of spontaneous symmetry breaking

Population pharmacokinetic analysis of pexidartinib in healthy subjects and patients with tenosynovial giant cell tumor or other solid tumors

Pexidartinib is a kinase inhibitor that induces tumor response and improvements in symptoms and functional outcomes in adult patients with symptomatic tenosynovial giant cell tumor (TGCT). A population pharmacokinetic (PK) model for pexidartinib and its metabolite, ZAAD, was developed, and effects of demographic and clinical factors on the PK of pexidartinib and ZAAD were estimated. The analysis included pooled data from 7 studies in healthy volunteers (N = 159) and 2 studies in patients with TGCT or other solid tumors (N = 216). A structural 2-compartment model with sequential zero- and first-order absorption and lag time, and linear elimination from the central compartment adequately described pexidartinib and ZAAD PKs. Clearance of pexidartinib was estimated at 5.83 L/h in a typical patient with reference covariates (male, non-Asian, weight = 80 kg, creatinine clearance >= 90 mL/min, aspartate aminotransferase <= 80 U/L, and total bilirubin <= 20.5 mu mol/L). In the covariate analysis, Asians and healthy subjects had modestly lower pexidartinib exposure (21% decrease each) in terms of steady-state area under the curve values from 0 to 24 hours (AUC(0-24,ss)). Effects of body weight, sex, and hepatic function parameters on pexidartinib AUC(0-24,ss)were generally <20%. Patients with TGCT with mild renal impairment were predicted to have approximately 23% higher AUC(0-24,ss)than those with normal renal function. The effects of covariates on ZAAD exposure were similar to those on pexidartinib. These results indicate small and generally clinically nonmeaningful effects of patient demographic and clinical characteristics on pexidartinib and ZAAD PK profiles.Experimentele farmacotherapi

Affective Man-Machine Interface: Unveiling human emotions through biosignals

As is known for centuries, humans exhibit an electrical profile. This profile is altered through various psychological and physiological processes, which can be measured through biosignals; e.g., electromyography (EMG) and electrodermal activity (EDA). These biosignals can reveal our emotions and, as such, can serve as an advanced man-machine interface (MMI) for empathic consumer products. However, such a MMI requires the correct classification of biosignals to emotion classes. This chapter starts with an introduction on biosignals for emotion detection. Next, a state-of-the-art review is presented on automatic emotion classification. Moreover, guidelines are presented for affective MMI. Subsequently, a research is presented that explores the use of EDA and three facial EMG signals to determine neutral, positive, negative, and mixed emotions, using recordings of 21 people. A range of techniques is tested, which resulted in a generic framework for automated emotion classification with up to 61.31% correct classification of the four emotion classes, without the need of personal profiles. Among various other directives for future research, the results emphasize the need for parallel processing of multiple biosignals

Exposure-response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor

This analysis was conducted to assess exposure-response relationships for efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor. Efficacy was assessed categorically by overall response rate (ORR) with Response Evaluation Criteria in Solid Tumors version 1.1 and longitudinally (changes in tumor size and volume). Safety included hepatic parameters (i.e., alanine aminotransferase [ALT], aspartate aminotransferase [AST], and total bilirubin). Average pexidartinib concentration (C-avg) was identified as the primary exposure parameter correlated with response. In categorical and longitudinal analyses, higher C-avg coincided with greater ORR and tumor size reduction, respectively, with smaller joint size having a greater impact. For safety, a significant relationship was observed between C-avg and incidence of ALT-related and AST-related adverse events (AEs). With increased exposure, an increase in efficacy was predicted with near maximum effect at 800 mg/day. Higher initial dose (1000 mg/day) during the first 2 weeks did not improve efficacy. Higher doses were associated with an increased risk of ALT-related and AST-related AEs. These results support the US Food and Drug Administration-approved dose (400 mg two times/day without initial loading dose).Experimentele farmacotherapi